Efficacy of a Multidomain Intervention on Lifestyle Risk Factors for Dementia Prevention
Tailored, Multidomain, and Coach-assisted Digital Program for the Adoption and Maintenance of a Healthy Lifestyle in Middle-aged and Older Adults With Modifiable Risk Factors for Dementia: An Efficacy Study
1 other identifier
interventional
370
1 country
1
Brief Summary
Alzheimer's Disease (AD) and other Dementias have far-reaching consequences on the lives of sufferers and their loved ones, not to mention the impact on the healthcare system. Several studies have identified protective lifestyle habits that might help reduce the risk of cognitive decline: cognitive engagement, physical activity, and a healthy diet. Our aim is to determine the efficacy of the Luci program, an online, coach-assisted, multidomain, behavioural intervention designed to help middle-aged to older adults reduce their risk of dementia by improving their lifestyle habits. In this study, we hope to demonstrate that participating in the Luci program helps to improve lifestyle habits and that the program could therefore become an effective health promotion tool.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for phase_3
Started Mar 2025
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
December 18, 2024
CompletedFirst Posted
Study publicly available on registry
December 27, 2024
CompletedStudy Start
First participant enrolled
March 13, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 1, 2026
CompletedStudy Completion
Last participant's last visit for all outcomes
October 1, 2026
ExpectedJanuary 12, 2026
January 1, 2026
12 months
December 18, 2024
January 9, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (4)
Lifestyle Risk Reduction criterion
The primary endpoint is the number of participants showing a clinically significant change (CSC) from Screening to Week 24 in at least one eligible domain (cognitive engagement, physical activity, mediterranean diet adherence).
Change from Screening to Week 24
Cognitive Engagement
Cognitive engagement is measured using the Vemuri Cognitive Activity Questionnaire. Participants are asked to indicate the frequency in which they engage in 10 types of cognitive leisure activities. Scores range from 0 to 70. A higher score represents a higher cognitive engagement level. A clinically significant change is defined as a 6-point minimum increase.
Screening, Week 12, Week 24, Week 52
Physical Activity
Physical activity is measured using the modified Godin-Shephard Leisure Time Physical Activity Questionnaire which consists of three sets of questions (6 items). An overall physical activity score is computed in Metabolic equivalent tasks (MET)-minutes/week, as well as a moderate-to-vigorous physical activity (MVPA) score. A higher MET value represents a higher physical activity level. A clinically significant change is defined as a 300 MET-min/week minimum increase in the MVPA score.
Screening, Week 12, Week 24, Week 52
Mediterranean Diet Adherence
Adherence to the Mediterranean Diet is measured with an adaptation of the Canadian Mediterranean Diet Scale. The scale consists of 13 questions on food consumption frequency and intake habits. Scores range from 0 to 13, where a higher score represents a higher adherence level. A clinically significant change is defined as a 2-point minimum increase.
Screening, Week 12, Week 24, Week 52
Secondary Outcomes (2)
Quality of Life
Baseline, Week 24, Week 52
Cognitive Performance
Screening, Week 24, Week 52
Other Outcomes (20)
Multifactorial index of dementia risk
Baseline, Week 24, Week 52
Perceived Stress
Screening, Week 24, Week 52
Sleep Quality
Baseline, Week 24, Week 52
- +17 more other outcomes
Study Arms (2)
Luci intervention
EXPERIMENTALParticipants enrolled in this group will receive the Luci intervention for a 24-week period.
Wait-list Control
NO INTERVENTIONParticipants in the waiting-list control group will not receive any intervention during the study. They will be invited to participate in the program at the end of the trial.
Interventions
The Luci intervention is a personalized behaviour change program delivered via an interactive web platform with the online support of a coach. It targets 3 lifestyle domains: physical activity, healthy diet and cognitive engagement. Participants will be encouraged to adopt a healthy lifestyle, as a means for cognitive decline/dementia risk reduction. This will be achieved by providing educational materials, practical tips and strategies, and by assisting participants outlining SMART goals to progressively adopt and maintain a healthier lifestyle. Coaching sessions will be held on a weekly basis from week 1 to 12, and every 2 weeks from week 13 to 24.
Eligibility Criteria
You may qualify if:
- Aged between 50 and 75;
- Proficient or native speakers in French or English;
- Computer literate defined as being able to read mails and browse the Internet, and having access to a computer or tablet with an Internet connection;
- Eligible in at least one of the 3 intervention domains, where eligibility is defined as follows:
- Low cognitive engagement in cognitively stimulating activities, defined as a score ≤ 22 on the adapted Cognitive Activity Questionnaire;
- Low level of physical activity defined as less than 150 minutes/week) of moderate to vigorous physical activity measured using the Godin- Shephard Leisure Time Physical Activity Questionnaire, and no medical contraindication to physical activity based on the Physical Readiness Questionnaire for Everyone (PAR-Q+);
- Low adherence to the Mediterranean-type diet defined as a score of ≤ 8 on the adapted Canadian Mediterranean Diet Scale, and no dietary restriction, severe allergy or intolerance or history of eating disorder.
You may not qualify if:
- Presence of a cognitive impairment as measured by the Creyos Dementia Assessment;
- General anesthesia within the last 6 months;
- Previous participation in the Luci program or in any validation studies related to the program;
- Current participation in another study;
- Unable to commit participation over the period of the study;
- Being in the precontemplation stage of change;
- High level of perceived stress;
- Having received a diagnosis of :
- Dementia or neurodegenerative disease (AD and other dementias);
- Past or present neurological disorder (multiple sclerosis, brain tumour, epilepsy, stroke, traumatic brain injury);
- Severe psychiatric disorder (schizophrenia, major depression, bipolar disorder);
- Diabetes or hypertension without medical monitoring;
- Alcoholism or drug addiction;
- Any other condition expected to limit participation (e.g., low visual acuity).
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- LuciLablead
- Sojecci II Ltdcollaborator
- Centre de Recherche de l'Institut Universitaire de Geriatrie de Montrealcollaborator
Study Sites (1)
Lucilab
Montreal, Quebec, H2T 1A8, Canada
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- phase 3
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
December 18, 2024
First Posted
December 27, 2024
Study Start
March 13, 2025
Primary Completion
March 1, 2026
Study Completion (Estimated)
October 1, 2026
Last Updated
January 12, 2026
Record last verified: 2026-01
Data Sharing
- IPD Sharing
- Will not share